Since no tumors were detected we conclude that loss of p53 and overexpression of MYCN, despite being expressed there, is either not sufficient for the development of medulloblastoma or spinal ependymoma or other promoters may be needed. The gene discussed is TP53; the disease is medulloblastoma.